Table 1.
Baseline Demographic and Clinical Characteristics of the Participants Divided in Three Trajectory Groups
| Low | Remitting | Persistent | |
|---|---|---|---|
| n=58 | n=69 | n=59 | |
| Female sex, n (%) 1 | 32 (55.2) | 43 (62.3) | 50 (84.7) |
| Age, years, mean (SD) | 18.9 (1.6) | 18.9 (1.7) | 19.0 (1.6) |
| SSRI, n (%) 2 | 21 (36.2) | 57 (82.6) | 41 (69.5) |
| History of suicide attempt, n (%) | 0 | 5 (7.2) | 5 (8.5) |
| GAD, n (%) 3 | 10 (17.2) | 27 (39.1) | 29 (49.2) |
| Alcohol use disorder, n (%) | 5 (8.6) | 13 (19.1) | 14 (23.7) |
| Cannabis use disorder, n (%) | 6 (10.3) | 9 (13.0) | 7 (11.9) |
| Social phobia, n (%) | 15 (25.9) | 20 (29.0) | 24 (40.7) |
| ADHD, n (%) | 6 (10.3) | 8 (11.6) | 8 (13.6) |
| Mean (SD) scores | |||
| Beck Depression Inventory4 | 6.7 (6.7) | 17.6 (9.8) | 18.6 (10.7) |
| Beck Anxiety Inventory5 | 6.7 (7.2) | 12.4 (10.4) | 12.8 (7.7) |
| Inventory of Depressive | 10.0 (7.0) | 20.6 (9.0) | 21.5 (10.4) |
| Symptomatology |
1
X2 = 12.8, p = .002; 2<3, X2 = .0, p = 0.005; 1<3, X2 = 12.2, p = .000
2
X2 = 30.6, p = .000; 1<2, X2 = 28.6, p = .000; 1<3, X2 = 13.0, p = .000
3
X2 = 13.6, p = 0.001; 1<2, X2 = 5.6, p = .014; 1<3, X2 = 13.0, p = .000
4
F = 30.4, p = 0.000; Bonferroni: 1<2, p = .000; 1<3, p = .000
5
F = 9.1, p = .000; Bonferroni: 1<2, p = .001; 1<3, p = .001
6
F = 31.0, p = .000; Bonferroni: 1<2, p = .000; 1<3, p = .000
SSRI: selective serotonin reuptake inhibitor use at study entry, GAD: generalized anxiety disorder ADHD: attention deficit hyperactivity disorder